Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.addr.2016.03.009PMID 27037063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium.

  2016cited by this paper
• Effects of meal type on the oral bioavailability of the ALK inhibitor ceritinib in healthy adult subjects

  2016cited by this paper
• Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.

  2016cited by this paper
• Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions

  2016cited by this paper
• Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.

  2015cited by this paper
• Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans.

  2015cited by this paper
• In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media.

  2015cited by this paper
• Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens

  2015cited by this paper
• Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies.

  2015cited by this paper
• Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state.

  2014cited by this paper
• Surface area of the digestive tract – revisited

  2014cited by this paper
• In vitro models for the prediction of in vivo performance of oral dosage forms.

  2014cited by this paper
• PBPK models for the prediction of in vivo performance of oral dosage forms.

  2014cited by this paper
• Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI.

  2014cited by this paper
• Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.

  2014cited by this paper
• Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel.

  2014cited by this paper
• Levothyroxine absorption in health and disease, and new therapeutic perspectives.

  2014cited by this paper
• Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.

  2014cited by this paper
• Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.

  2014cited by this paper
• Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives

  2014cited by this paper
• Development of pressure-sensitive dosage forms with a core liquefying at body temperature.

  2014cited by this paper
• A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.

  2014cited by this paper
• Is the full potential of the biopharmaceutics classification system reached?

  2014cited by this paper
• Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.

  2013cited by this paper
• The Acid Pocket: A Target for Treatment in Reflux Disease?

  2013cited by this paper
• An Automated System for Monitoring and Regulating the pH of Bicarbonate Buffers

  2013cited by this paper
• Simulating the postprandial stomach: physiological considerations for dissolution and release testing.

  2013cited by this paper
• Oral Anticancer Drugs: Back to Square One

  2013cited by this paper
• A new method for determining gastric acid output using a wireless pH‐sensing capsule

  2013cited by this paper
• Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI

  2013cited by this paper
• An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs

  2012cited by this paper
• The migrating motor complex: control mechanisms and its role in health and disease

  2012cited by this paper
• Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials

  2011cited by this paper
• Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.

  2011cited by this paper
• In vivo imaging of drug delivery systems in the gastrointestinal tract.

  2011cited by this paper
• Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data

  2011cited by this paper
• Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.

  2010cited by this paper
• Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome.

  2010cited by this paper
• Gastric emptying of multi-particulate dosage forms.

  2010cited by this paper
• Dynamic dissolution: a step closer to predictive dissolution testing?

  2010cited by this paper
• Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.

  2010cited by this paper
• Inconsistent Labeling of Food Effect for Oral Agents across Therapeutic Areas: Differences between Oncology and Non-Oncology Products

  2010cited by this paper
• A biorelevant dissolution stress test device – background and experiences

  2010cited by this paper
• The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging

  2009cited by this paper
• The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD

  2009cited by this paper
• Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging

  2009cited by this paper
• Influence of food intake on the bioavailability and efficacy of oral calcitonin.

  2009cited by this paper
• Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.

  2009cited by this paper
• Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.

  2009cited by this paper
• Characterization of the behavior of alginate-based microcapsules in vitro and in vivo.

  2009cited by this paper
• Population-Based Mechanistic Prediction of Oral Drug Absorption

  2009cited by this paper
• Disintegration of solid foods in human stomach.

  2008cited by this paper
• Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy

  2008cited by this paper
• Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic

  2008cited by this paper
• Gut instincts: explorations in intestinal physiology and drug delivery.

  2008cited by this paper
• Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.

  2008cited by this paper
• Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine

  2008cited by this paper
• New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

  2008cited by this paper
• Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin

  2008cited by this paper
• Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.

  2008cited by this paper
• The influence of non‐disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers

  2007cited by this paper
• Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

  2007cited by this paper
• Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.

  2007cited by this paper
• The effect of macronutrients on gastric volume responses and gastric emptying in humans: A magnetic resonance imaging study.

  2007cited by this paper
• Integrated upper gastrointestinal response to food intake.

  2006cited by this paper
• Imaging and modelling of digestion in the stomach and the duodenum

  2006cited by this paper
• Quantification of distal antral contractile motility in healthy human stomach with magnetic resonance imaging

  2006cited by this paper
• Fasting from midnight--the history behind the dogma.

  2006cited by this paper
• Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers

  2005cited by this paper
• Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms.

  2005cited by this paper
• Impact of the intragastric location of extended release tablets on food interactions.

  2005cited by this paper
• Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging

  2005cited by this paper
• Gastrointestinal Transit and Drug Absorption

  2005cited by this paper
• Lead- and drug-like compounds: the rule-of-five revolution.

  2004cited by this paper
• Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.

  2004cited by this paper
• The Effect of Intravenous Pantoprazole and Ranitidine for Improving Preoperative Gastric Fluid Properties in Adults Undergoing Elective Surgery

  2003cited by this paper
• Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice

  2003cited by this paper
• Enteric coated HPMC capsules designed to achieve intestinal targeting.

  2002cited by this paper
• Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.

  2002cited by this paper
• Physiological assessment of the function of the ileocecal junction with evidence of ileocecal junction reflexes.

  2002cited by this paper
• Monitoring the Intragastric Distribution of a Colloidal Drug Carrier Model by Magnetic Resonance Imaging

  2001cited by this paper
• Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI.

  2001cited by this paper
• Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration

  1999cited by this paper
• Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules.

  1999cited by this paper
• A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products

  1999cited by this paper
• Human duodenogastric reflux, retroperistalsis, and MMC.

  1998cited by this paper
• Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III.

  1998cited by this paper
• Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs

  1998cited by this paper
• Human duodenogastric reflux, retroperistalsis, and MMC.

  1998cited by this paper
• Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III.

  1998cited by this paper
• Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile.

  1997cited by this paper
• Nocturnal Antral pH Rises Are Related to Duodenal Phase III Retroperistalsis

  1997cited by this paper
• Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women

  1997cited by this paper
• The in vivo behaviour of enteric naproxen tablets coated with an aqueous dispersion of methacrylic acid copolymer

  1997cited by this paper
• Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules

  1994cited by this paper
• The effect of food on the in vivo behaviour of enteric coated starch capsules

  1994cited by this paper
• An in Vitro/in Vivo Correlation for the Disintegration and Onset of Drug Release from Enteric-Coated Pellets

  1993cited by this paper
• The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy

  1993cited by this paper
• In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy

  1992cited by this paper
• Variability of migrating motor complex in humans

  1992cited by this paper

• Effects of Food on the Bioavailability of Medicinal Products in Bioequivalence Studies: A Comparative Analysis of Regulatory Documents

  2025cites this paper
• Dual-responsive micromotor pill for targeted retention in the intestines in vivo.

  2025cites this paper
• Intraluminal enzymatic hydrolysis of API and lipid or polymeric excipients.

  2025cites this paper
• Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation

  2025influential citation
• ASSESSMENT OF BIORELEVANT MEDIA TO ANTICIPATE FOOD EFFECT OF ORAL RITONAVIR AMORPHOUS SOLID DISPERSIONS

  2025cites this paper
• Unleashing photothermocatalysis potential for enhanced pathogenic bacteria inactivation

  2025cites this paper
• Impact of Food Physical Properties on Oral Drug Absorption: A Comprehensive Review

  2025cites this paper
• Localized Drug Delivery in Different Gastrointestinal Cancers: Navigating Challenges and Advancing Nanotechnological Solutions

  2025cites this paper
• Development of a Universal In Vivo Predictive Dissolution Method for a Borderline BCS III/IV Drug Guided by Modeling and SimulationsAcyclovir as a Case Study

  2025cites this paper
• Formulation and evaluation of novel amine-functionalised KIT-6 mesoporous silica loaded with berberine and fluconazole for drug delivery applications

  2025cites this paper
• Multifunctional self-emulsifying drug delivery system: an efficient strategy for oral delivery of therapeutic peptides and proteins

  2025influential citation
• Does the appearance of the Magenstrasse depend on the amount of water consumed?

  2025cites this paper
• Research progress on the performance of expandable systems for long-term gastric retention.

  2025cites this paper
• Applications of bacteriophages in precision engineering of the human gut microbiome

  2025cites this paper
• In Silico Studies of Fluid Flow, Digestion of Food and Drug Dissolution in Human Stomach

  2025cites this paper
• Intra‐ and interindividual variability in fasted gastric content volume

  2024cites this paper
• Compare and PASS - Fast screening of oral dosage forms for bioequivalence probability with the COMPASS software.

  2024cites this paper
• Exopeptidase combination enhances the degradation of isotopically labelled gluten immunogenic peptides in humans

  2024cites this paper
• Changes in Drug Crystallinity in a Commercial Tacrolimus Amorphous Formulation Result in Variable Pharmacokinetics.

  2024cites this paper
• A quantification of gastric and duodenal fluid volumes in older adults using MRI.

  2024cites this paper
• Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics

  2024influential citation
• Application of a Novel Dissolution Medium with Lipids for In Vitro Simulation of the Postprandial Gastric Content

  2024cites this paper
• Impact of advanced age on the gastric emptying of water under fasted and fed state conditions.

  2024cites this paper
• More Than a Gut Feeling—A Combination of Physiologically Driven Dissolution and Pharmacokinetic Modeling as a Tool for Understanding Human Gastric Motility

  2024cites this paper
• Enteric-Coated Capsules Providing Reliable Site-Specific Drug Delivery to the Distal Ileum

  2024cites this paper
• Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet.

  2024cites this paper
• Predicting gastric emptying of drug substances taken under postprandial conditions by combination of biorelevant dissolution and mechanistic in silico modeling.

  2024cites this paper
• Is there a fast track ("Darmstrasse") for fluids in the small intestine? evidence from magnetic resonance imaging.

  2024cites this paper
• In Vitro Simulation of the Fasted Gastric Conditions and Their Variability to Elucidate Contrasting Properties of the Marketed Dabigatran Etexilate Pellet-Filled Capsules and Loose Pellets.

  2024cites this paper
• Bilayer-functionalized mesoporous silica nanoparticles for overcoming multiple barriers of mucus clearance, intestinal epithelium and P-glycoprotein efflux

  2024cites this paper
• Comparing the gastric emptying of 240 mL and 20 mL water by MRI and caffeine salivary tracer technique.

  2023cites this paper
• Untethered shape-changing devices in the gastrointestinal tract

  2023cites this paper
• pH-dependent pressure-sensitive colonic capsules for the delivery of aqueous bacterial suspensions.

  2023cites this paper
• An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics - a study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients.

  2023cites this paper
• Drug Dissolution in Oral Drug Absorption: Workshop Report

  2023cites this paper
• Determination of Gastric Water Emptying in Fasted and Fed State Conditions Using a Compression-Coated Tablet and Salivary Caffeine Kinetics

  2023cites this paper
• In Vivo Evaluation of a Gastro-Resistant Enprotect® Capsule under Postprandial Conditions

  2023cites this paper
• Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease.

  2023cites this paper
• Structured solubility behaviour in fed simulated intestinal fluids.

  2023cites this paper
• Digitalizing the TIM-1 Model using Computational Approaches-Part One: TIM-1 Data Explorer.

  2023cites this paper
• Quantitative analysis of gastrointestinal fluid absorption and secretion to estimate luminal fluid dynamics in rats

  2023cites this paper
• Recent Progress in Diatom Biosilica: A Natural Nanoporous Silica Material as Sustained Release Carrier

  2023cites this paper
• Optical Integration in Wearable, Implantable and Swallowable Healthcare Devices.

  2023cites this paper
• Physiological Dynamics in the Upper Gastrointestinal Tract and the Development of Gastrointestinal Absorption Models for the Immediate-Release Oral Dosage Forms in Healthy Adult Human

  2023cites this paper
• Bioequivalence of Blonanserin Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects

  2023cites this paper
• The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference.

  2023cites this paper
• Recent progress in tannic acid based approaches as a natural polyphenolic biomaterial for cancer therapy: A review.

  2023cites this paper
• From In Vitro to In Vivo: A Comprehensive Guide to IVIVC Development for Long-Acting Therapeutics.

  2023cites this paper
• Supramolecular Polymer‐Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage‐Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti‐Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma

  2023cites this paper
• Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations - a case study workflow for in vitro-in vivo predictions.

  2023cites this paper
• Intragastric Carbon Dioxide Release Prolongs the Gastric Residence Time of Postprandially Administered Caffeine

  2023cites this paper
• Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects

  2023cites this paper
• Mesoporous silica nanoparticles with chiral pattern topological structure function as "antiskid tires" on the intestinal mucosa to facilitate oral drugs delivery.

  2023cites this paper
• Application of biorelevant in vitro assays for the assessment and optimization of ASD-based formulations for pediatric patients.

  2023cites this paper
• Improving solubility of poorly water-soluble drugs by protein-based strategy: a review.

  2023cites this paper
• Effect of Ingested Fluid Volume and Solution Osmolality on Intestinal Drug Absorption: Impact on Drug Interaction with Beverages.

  2022cites this paper
• Bridging the Gap between Food Effects under Clinical Trial Conditions and Real Life: Modeling Delayed Gastric Emptying of Drug Substances and Gastric Content Volume Based on Meal Characteristics.

  2022cites this paper
• Digestion of meat proteins in a human-stomach: A CFD simulation study

  2022cites this paper
• Gastroretentive dosage forms

  2022cites this paper
• Mucus-penetrating dendritic mesoporous silica nanoparticle loading drug nanocrystal clusters to enhance permeation and intestinal absorption.

  2022cites this paper
• Interaction of polymers with bile salts - Impact on solubilisation and absorption of poorly water-soluble drugs.

  2022cites this paper
• Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules

  2022cites this paper
• Food-Drug Interactions - A Short Review of the Particularities of Pharmacokinetics and Pharmacodynamics Molecular Stage Correlations

  2022cites this paper
• Ultralong floating hydrogel raft for prolonged gastric retention

  2022cites this paper
• Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin

  2022cites this paper
• Numerical modeling of the dissolution of drug nanocrystals and its application to industrial product development

  2022cites this paper
• Administration strategies and smart devices for drug release in specific sites of the upper GI tract.

  2022cites this paper
• The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives

  2022cites this paper
• Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research

  2022cites this paper
• Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.

  2022cites this paper
• In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications

  2022cites this paper
• Computational modeling of drug dissolution in the human stomach: Effects of posture and gastroparesis on drug bioavailability.

  2022cites this paper
• Computational Modeling of Drug Dissolution in the Human Stomach

  2022cites this paper
• Food–drug interactions and their implications on oral drug bioavailability

  2022cites this paper
• Ingestible devices for studying the gastrointestinal physiology and their application in oral biopharmaceutics.

  2021cites this paper
• Mixing and emptying of gastric contents in human-stomach: A numerical study.

  2021cites this paper
• Oral drug delivery: Conventional to Long Acting New-Age Designs.

  2021cites this paper
• Leveraging Oral Drug Development to a Next Level: Impact of the IMI-Funded OrBiTo Project on Patient Healthcare

  2021cites this paper
• Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: an UNGAP review.

  2021cites this paper
• Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations

  2021cites this paper
• Evaluating the impact of physiological properties of the gastrointestinal tract on drug in vivo performance using Physiologically Based Biopharmaceutics Modeling and virtual clinical trials.

  2021cites this paper
• Physical methods for enhancing drug absorption from the gastrointestinal tract.

  2021cites this paper
• Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug–Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models

  2021cites this paper
• In vitro models to evaluate ingestible devices: present status and current trends.

  2021cites this paper
• Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy

  2021cites this paper
• Impact of Anatomy and Physiology

  2021cites this paper
• Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection.

  2020influential citation
• Preparation of the Rutin-SBA-16 Drug Delivery System

  2020cites this paper
• Mechanistic study of model drug release from HPMC matrices in fed gastric media

  2020cites this paper
• Succinylated casein functionalized mesoporous silica nanoplatforms to overcome multiple gastrointestinal barriers

  2020cites this paper
• A Review of Current Methods for Food Effect Prediction During Drug Development

  2020cites this paper
• In Vitro Biopredictive Methods: A Workshop Summary Report.

  2020cites this paper
• Prediction of Fasted and Fed Bioequivalence for Immediate Release Drug Products using Physiologically based Biopharmaceutics Modeling (PBBM).

  2020cites this paper
• A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base Albendazole and its main metabolite Albendazole Sulfoxide.

  2020cites this paper
• High stability of plant-expressed virus-like particles of an insect virus in artificial gastric and intestinal fluids.

  2020cites this paper
• The Effects of Dose Volume and Excipient Dose on Luminal Concentration and Oral Drug Absorption

  2020cites this paper
• Micro and nanoscale technologies in oral drug delivery

  2020cites this paper
• Multidimensional analysis of human intestinal fluid composition.

  2020cites this paper
• The tangential flow absorption model (TFAM) - a novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives.

  2020cites this paper
• Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir® Tablet Absorption in Humans Under Fasted and Fed State Conditions.

  2020cites this paper